Award of Merit Manufacturing: TEVA Biologics Manufacturing Facility | 2018-10-16 | Engineering News-Record
Why Teva Pharmaceuticals Stock Has Two A-Products In The Bag (NYSE:TEVA) | Seeking Alpha
Pharma giant moving Pa. headquarters to N.J., creating hundreds of jobs - lehighvalleylive.com
/cloudfront-us-east-2.images.arcpublishing.com/reuters/ANJL4AXVTBOMDKS2X4DIJZXZAY.jpg "Teva loses bid to cancel Corcept drug patent at Federal Circuit | Reuters")
Teva loses bid to cancel Corcept drug patent at Federal Circuit | Reuters
Buffett's Berkshire adds to Teva stake in the first quarter
Teva: Great Investment With An Upside Even In Volatile Markets (NYSE:TEVA) | Seeking Alpha
Patients Eagerly Awaited a Generic Drug. Then They Saw the Price. - The New York Times
Teva Narrows Losses in 2019 – Business News From Israel
Teva Announces New Brand Positioning and Visual Identity in North America
15. Teva Pharmaceutical Industries | FiercePharma
Teva Pharmaceutical Industries (NYSE:TEVA) Seems To Be Using A Lot Of Debt - Simply Wall St News
ADDING MULTIMEDIA Teva Announces U.S. Approval of AJOVYTM (fremanezumab-vfrm) Injection, the First and Only Anti-CGRP Treatment with Both Quarterly and Monthly Dosing for the Preventive Treatment of Migraine in Adults | Business
A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New York Times
Teva Wins Three, Loses Six in Patent Battle Over Migraine Drug | BioSpace
Teva Migraine Drug Wins FDA Approval | Fortune
Teva Pharmaceutical falls 6% on eve of Q3 earnings show | Seeking Alpha
Teva Pharmaceuticals to lay off 14,000 employees worldwide, 1,750 in Israel - The Jerusalem Post
Teva Execs Topped TASE's High Earners List for 2018 | Ctech
Teva down as it reports lower sales and profit for 2018
Teva Stock Dives As The Sales Downfall Continues For Its Biggest Product | Investor's Business Daily
Teva launches generic EpiPen Jr. - Drug Delivery Business
